HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions... Show more
HealthEquity, Inc. operates as a leading provider of technology-enabled services platforms for health savings accounts and other consumer-directed benefits in the United States. The company maintains a strong competitive position through its integrated platform that combines account administration, investment options, and employer solutions. Market share trends favor established HSA custodians like HealthEquity amid ongoing consolidation in the benefits administration space. Product pipeline initiatives focus on enhancing digital tools and expanding service offerings to support growing HSA adoption. Medium-term positioning benefits from network effects in the HSA ecosystem, though structural risks include potential disruption from fintech entrants or shifts in employer benefit strategies.
Upcoming earnings releases will provide updates on account growth, assets under management, and margin trends, influencing investor views on execution. Recent management commentary highlighted raised fiscal 2027 guidance, reflecting optimism around new HSA additions and operational efficiency. Analyst rating changes and price-target revisions remain relevant, with the current consensus reflecting a Moderate Buy stance and an average target around $112 from roughly 15 covering firms. Strategic partnerships or capital allocation decisions, such as share repurchases, could further support sentiment. Regulatory decisions on healthcare accounts may also serve as inflection points by either expanding or constraining the addressable market for HSAs.
The broader environment for HealthEquity ties directly to healthcare cost inflation and evolving consumer preferences for high-deductible health plans paired with HSAs. Interest rate movements affect yields earned on cash balances within accounts, impacting revenue streams tied to float income. Inflation trends and consumer demand cycles influence enrollment patterns, while technology adoption supports digital platform enhancements. Regulatory climate around tax-advantaged benefits and potential policy shifts in healthcare financing represent key variables that could shape demand and competitive dynamics over the medium term.
The Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality. Trend Prediction Engine
Looking to fiscal 2027 and beyond, HealthEquity’s trajectory hinges on continued expansion of its HSA customer base and assets under administration. Long-term structural drivers include sustained growth in consumer-directed healthcare benefits and opportunities to deepen penetration among employers. Cost structure evolution through scale efficiencies supports margin sustainability, while technology transitions enhance platform capabilities. Competitive threats from integrated payers or alternative savings vehicles warrant monitoring. Regulatory developments around healthcare accounts and capital allocation priorities, including potential investments or returns to shareholders, will influence sentiment. Consensus analyst expectations reflect measured optimism, with price targets clustered in the low-to-mid $110 range based on current coverage.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a provider of solutions for managing health care accounts
Industry ServicestotheHealthIndustry
A.I.dvisor indicates that over the last year, HQY has been loosely correlated with EVCM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HQY jumps, then EVCM could also see price increases.
| Ticker / NAME | Correlation To HQY | 1D Price Change % | ||
|---|---|---|---|---|
| HQY | 100% | -1.55% | ||
| EVCM - HQY | 47% Loosely correlated | -0.44% | ||
| CPAY - HQY | 46% Loosely correlated | -0.74% | ||
| HUBS - HQY | 46% Loosely correlated | -1.02% | ||
| ALKT - HQY | 43% Loosely correlated | +0.89% | ||
| PCOR - HQY | 43% Loosely correlated | +0.09% | ||
More | ||||
| Ticker / NAME | Correlation To HQY | 1D Price Change % |
|---|---|---|
| HQY | 100% | -1.55% |
| Services to the Health Industry industry (46 stocks) | 32% Poorly correlated | +0.44% |
| Health Services industry (247 stocks) | 4% Poorly correlated | -0.03% |
HQY moved above its 50-day moving average on May 13, 2026 date and that indicates a change from a downward trend to an upward trend. In of 38 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where HQY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HQY advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 274 cases where HQY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Momentum Indicator moved below the 0 level on June 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HQY as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for HQY turned negative on June 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HQY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
HQY broke above its upper Bollinger Band on May 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HQY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.551) is normal, around the industry mean (7.560). P/E Ratio (32.573) is within average values for comparable stocks, (50.229). Projected Growth (PEG Ratio) (1.245) is also within normal values, averaging (1.180). Dividend Yield (0.000) settles around the average of (0.045) among similar stocks. P/S Ratio (5.634) is also within normal values, averaging (5.686).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HQY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.